Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

Cited by (1,001)

Items 501–600 of 1,001

1. Transcriptome analysis of embryonic mammary cells reveals insights into mammary lineage establishment
   Olivia Wansbury, Alan G. Mackay, Naoko Kogata, Costas Mitsopoulos, Howard D. Kendrick, Kathryn Davidson, Christiana Ruhrberg, Jorge Sergio Reis-Filho, Matthew John Smalley, Marketa Zvelebil et al. · 2011 · Breast Cancer Research
2. Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cells
   Jia Ke, Zhiju Zhao, Su‐Hyung Hong, Shoumin Bai, Zhen He, Fayaz Ahmad Malik, Jiahui Xu, Lei Zhou, Weilong Chen, Rachel Martin-Trevino et al. · 2015 · Oncotarget
3. Heterogeneity of Neoplastic Stem Cells: Theoretical, Functional, and Clinical Implications
   Peter Valent, Dominique A. Bonnet, Stefan Wöhrer, Michael Andreeff, Mhairi Copland, Christine Chomienne, Connie J. Eaves · 2013 · Cancer Research
4. Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining Pathway
   Clare E. Weeden, Yunshun Chen, Stephen B. Ma, Yifang Hu, Georg Ramm, Kate D. Sutherland, Gordon K. Smyth, Marie-Liesse Asselin-Labat · 2017 · PLoS Biology
5. The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity
   Shunsuke Kitajima, Akiyo Yoshida, Susumu Kohno, Fei Li, Sawako Suzuki, Nao Nagatani, Y Nishimoto, Nobunari Sasaki, Hayato Muranaka, Yuansong Wan et al. · 2017 · Oncogene
6. Myoepithelial cell‐specific expression of stefin A as a suppressor of early breast cancer invasion
   Hendrika M. Duivenvoorden, Jai Rautela, Laura E. Edgington‐Mitchell, Alex Spurling, David W. Greening, Cameron J. Nowell, Timothy J. Molloy, Elizabeth Robbins, Natasha K. Brockwell, Cheok Soon Lee et al. · 2017 · The Journal of Pathology
7. Cell polarity in morphogenesis and metastasis
   Ian G. Macara, Luke Martin McCaffrey · 2013 · Philosophical Transactions of the Royal Society B Biological Sciences
8. Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management
   Emad A. Rakha, Sunil Badve, Vincenzo Eusebi, Jorge Sergio Reis-Filho, Stephen B. Fox, David J. Dabbs, Thomas W. Decker, Zsolt Hodi, Shu Ichihara, Andrew H.S. Lee et al. · 2015 · Histopathology
9. Mammary epithelial cells have lineage-rooted metabolic identities
   Mathepan Jeya Mahendralingam, Hye‐Yeon Kim, Curtis W. McCloskey, Kazeera Aliar, Alison E. Casey, Pirashaanthy Tharmapalan, Davide Pellacani, Vladimir Ignatchenko, Mar García-Valero, Luís Palomero et al. · 2021 · Nature Metabolism
10. MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene
    Yu Wei Phua, Akira Nguyen, Daniel Lee Roden, Benjamin Elsworth, Niantao Deng, Iva Nikolić, Jessica Yang, Andrea McFarland, Roslin Russell, Warren H. Kaplan et al. · 2015 · Breast Cancer Research
11. Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
    Nadine Tung, Alexander Miron, Stuart J. Schnitt, Shiva Gautam, Katharina Fetten, Jennifer Kaplan, Yosuf Yassin, Ayodele Buraimoh, Ji-Young Kim, Attila Marcell Szász et al. · 2010 · Breast Cancer Research
12. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions
    Oihana Iriondo, Miriam Rábano, Giacomo Domenici, Onintza Carlevaris, José Antonio López-Ruiz, Ignacio Zabalza, Edurne Berra, María dM Vivanco · 2015 · Oncotarget
13. Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy
    Jens Henrik Norum, K Andersen, Thérese Sørlie · 2014 · British journal of surgery
14. CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes
    Bianca Mostert, Jaco Kraan, Anieta M. Sieuwerts, Petra van der Spoel, Joan Bolt‐de Vries, Wendy J. C. Prager‐van der Smissen, Marcel Smid, A. Mieke Timmermans, John W.M. Martens, Jan Willem Gratama et al. · 2011 · Cancer Letters
15. Biomarkers for Basal-like Breast Cancer
    Jennifer R. Choo, Torsten O. Nielsen · 2010 · Cancers
16. Enhancer alterations in cancer: a source for a cell identity crisis
    Ken J. Kron, Swneke Donovan Bailey, Mathieu Lupien · 2014 · Genome Medicine
17. Concise Review: Breast Cancer Stem Cells: Regulatory Networks, Stem Cell Niches, and Disease Relevance
    Wenjun Guo · 2014 · Stem Cells Translational Medicine
18. The Wnt-Myb pathway suppresses KIT expression to control the timing of salivary proacinar differentiation and duct formation
    Shinji Matsumoto, Takayuki Kurimoto, Makoto Mark Taketo, Shinsuke Fujii, Akira Kikuchi · 2016 · Development
19. Signaling pathways essential for triple-negative breast cancer stem-like cells
    Sidse Ehmsen, Henrik J. Ditzel · 2020 · Stem Cells
20. Distinct nuclear receptor expression in stroma adjacent to breast tumors
    Kevin C. Knower, Ashwini L. Chand, Natalie A. Eriksson, Kiyoshi Takagi, Yasuhiro Miki, Hironobu Sasano, Jane E. Visvader, Geoffrey John Lindeman, John W. Funder, Peter J. Fuller et al. · 2013 · Breast Cancer Research and Treatment
21. Adult lung stem cells and their contribution to lung tumourigenesis
    Marie-Liesse Asselin-Labat, Caitlin E. Filby · 2012 · Open Biology
22. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features
    Gülnur Güler, Çiğdem Himmetoğlu, Rafael E. Jiménez, Susan Michelle Geyer, Wenle P. Wang, Stefan Costinean, Robert Pilarski, Carl Morrison, Dinç Süren, Jianhua Liu et al. · 2010 · Breast Cancer Research and Treatment
23. The bed and the bugs: Interactions between the tumor microenvironment and cancer stem cells
    Zafira Castaño, Christine F. Brainson, Carla F. Kim, Sandra S. McAllister · 2012 · Seminars in Cancer Biology
24. Progesterone-Inducible Cytokeratin 5-Positive Cells in Luminal Breast Cancer Exhibit Progenitor Properties
    Sunshine Daddario Axlund, Byong Hoon Yoo, Rachel B. Rosen, Jerome B. Schaack, Peter Kabos, Daniel V. LaBarbera, Carol A. Sartorius · 2012 · Hormones and Cancer
25. Cellular Mechanisms Underlying Intertumoral Heterogeneity
    Kate D. Sutherland, Jane E. Visvader · 2015 · Trends in cancer
26. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer
    K Sakamoto, Aleata A. Triplett, LA Schuler, K-U Wagner · 2010 · Oncogene
27. Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis
    Qi Sun, Jacqueline Lesperance, Hiromi Inoue Wettersten, Elaine Luterstein, Yoko S. DeRose, Alana L. Welm, David A. Cheresh, Jay S. Desgrosellier · 2017 · Journal of Clinical Investigation
28. Epigenomics of mammary gland development
    Holly Holliday, Laura A. Baker, Simon R. Junankar, Susan J. Clark, Alexander Swarbrick · 2018 · Breast Cancer Research
29. Midkine as a driver of age-related changes and increase in mammary tumorigenesis
    Pengze Yan, Ernesto Arturo Rojas-Jiménez, Zheqi Li, Triet Minh Bui, Marco Seehawer, Jun Nishida, Pierre Foidart, Laura E. Stevens, Yingtian Xie, Miguel Muñoz Gomez et al. · 2024 · Cancer Cell
30. Mouse Models of Breast Cancer
    Kazuhito Sakamoto, Jeffrey W. Schmidt, Kay‐Uwe Wagner · 2015 · Methods in molecular biology
31. Transcription factor regulatory networks in mammary epithelial development and tumorigenesis
    Peter M. Siegel, William J. Muller · 2010 · Oncogene
32. Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers
    Anita L. Bane, Alicia Viloria‐Petit, Dushanthi Pinnaduwage, Anna Marie Mulligan, Frances P. O’Malley, Irene Louise Andrulis · 2013 · Breast Cancer Research and Treatment
33. The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes
    Amulya Sreekumar, Kevin P. Roarty, Jeffrey M. Rosen · 2015 · Endocrine Related Cancer
34. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression
    Kevin P. Roarty, Adam D. Pfefferle, Chad J. Creighton, Charles M. Perou, Jeffrey M. Rosen · 2017 · Oncogene
35. Progesterone stimulates progenitor cells in normal human breast and breast cancer cells
    Heidi N. Hilton, N. Santucci, Audrey Silvestri, Silke Kantimm, L. I. Huschtscha, J. Dinny Graham, Christine L. Clarke · 2014 · Breast Cancer Research and Treatment
36. Oncobiology and treatment of breast cancer in young women
    Rakesh Kumar, Catarina Abreu, Masakazu Toi, Sunil Saini, Sandra Casimiro, Anshika Arora, Aswathy Mary Paul, Ravi Velaga, Pranela Rameshwar, Allan Lipton et al. · 2022 · Cancer and Metastasis Reviews
37. Cancer Stem Cells: Constantly Evolving and Functionally Heterogeneous Therapeutic Targets
    Tao Yang, Kiera Rycaj, Zhong-Min Liu, Dean G. Tang · 2014 · Cancer Research
38. The Cell of Origin of BRCA1 Mutation-associated Breast Cancer: A Cautionary Tale of Gene Expression Profiling
    Gemma Molyneux, Matthew John Smalley · 2011 · Journal of Mammary Gland Biology and Neoplasia
39. Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast
    Heidi N. Hilton, J. Dinny Graham, Silke Kantimm, N. Santucci, D. Cloosterman, L. I. Huschtscha, Patricia A. Mote, Christine L. Clarke · 2012 · Molecular and Cellular Endocrinology
40. Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer
    Diego Caliari, Valentina Zappulli, Roberta Rasotto, Barbara Cardazzo, Federica Frassineti, Michael H. Goldschmidt, Massimo Castagnaro · 2014 · BMC Veterinary Research
41. IGF1R Inhibition in Mammary Epithelia Promotes Canonical Wnt Signaling and Wnt1-Driven Tumors
    Lauren M. Rota, Lidia Albanito, Marcus E. Shin, Corey Goyeneche, Шушанов Саин Сакенович, Emily J. Gallagher, Derek LeRoith, Deborah A. Lazzarino, Teresa L. Wood · 2014 · Cancer Research
42. Expression of MAGE ‐A and NY ‐ ESO ‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers
    Ashwini Raghavendra, Priyakshi Kalita‐de Croft, Ana Cristina Vargas, Chanel Elisha Smart, Peter T. Simpson, Jodi M. Saunus, Sunil R. Lakhani · 2018 · Histopathology
43. c-Kit+ Cells in Adult Salivary Glands do not Function as Tissue Stem Cells
    Mingyu Kwak, Ninche Ninche, Sabine Klein, Dieter Saur, Soosan Ghazizadeh · 2018 · Scientific Reports
44. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer
    Chang-Ching A. Lin, Miao‐Chia Lo, Rebecca Moody, Hui Jiang, Ramdane A Harouaka, Nicholas O. Stevers, Samantha L. Tinsley, Mari Gasparyan, Max S. Wicha, Duxin Sun · 2018 · Cancer Letters
45. Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress
    Sarah Hein, Svasti Haricharan, A N Johnston, M J Toneff, Jay Paul Reddy, Jie Dong, Wen Bu, Yi Li · 2015 · Oncogene
46. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis
    Xiong Liu, Feng Bai, Yuchan Wang, Chuying Wang, Ho Lam Chan, Chenglong Zheng, Jian Chen Fang, Wei‐Guo Zhu, Xin‐Hai Pei · 2023 · Cell Death and Disease
47. Wip1 phosphatase in breast cancer
    Alexander Emelyanov, Dmitry V. Bulavin · 2014 · Oncogene
48. Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes
    Felicia Leccia, Agostina Nardone, Sara Corvigno, Luigi Del Vecchio, Sabino De Placido, Francesco Salvatore, Bianca Maria Veneziani · 2012 · Cytometry Part A
49. Stem Cells and the Developing Mammary Gland
    Maisam Makarem, Benjamin T. Spike, Christopher Dravis, Nagarajan Kannan, Geoffrey M. Wahl, Connie J. Eaves · 2013 · Journal of Mammary Gland Biology and Neoplasia
50. Integrin Signaling in Mammary Epithelial Cells and Breast Cancer
    Arthur W. Lambert, Sait Ozturk, Sam Thiagalingam · 2012 · ISRN Oncology
51. MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition
    Andrew DeCastro, Karen A. Dunphy, Justine A. Hutchinson, Amanda Balboni, Pratima Cherukuri, D. Joseph Jerry, James DiRenzo · 2013 · Cell Death and Disease
52. Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation
    Elizabeth M. Kass, Pei Xin Lim, Hildur R. Helgadottir, Mary Ellen Moynahan, Maria Jasin · 2016 · Nature Communications
53. R code and downstream analysis objects for the scRNA-seq atlas of normal and tumorigenic human breast tissue
    Yunshun Chen, Bhupinder Pal, Geoffrey John Lindeman, Jane E. Visvader, Gordon K. Smyth · 2022 · Scientific Data
54. Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice
    Christine B. Ambrosone, Michael J. Higgins · 2020 · Cancer Research
55. Prostate cancer stem cell biology.
    Chunyan Yu, Zhi Yao, Yuan Jiang, Evan T. Keller · 2012 · PubMed
56. Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture
    Liting Jin, Ying Qu, Liliana J. Gomez, Stacey Chung, Bingchen Han, Bowen Gao, Yong Yue, Yiping Gong, Xuefeng Liu, Farin F. Amersi et al. · 2017 · Oncotarget
57. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression
    Chuying Wang, Feng Bai, Li-han Zhang, Alexandria Scott, Enxiao Li, Xin‐Hai Pei · 2018 · Breast Cancer Research
58. Regulation of Cellular Heterogeneity and Rates of Symmetric and Asymmetric Divisions in Triple-Negative Breast Cancer
    Roy Zvi Granit, Hadas Masury, Reba Condiotti, Yaakov Fixler, Yael Gabai, Tzofia Glikman, Simona Dalin, Eitan E. Winter, Yuval Nevo, Einat Carmon et al. · 2018 · Cell Reports
59. Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carriers
    Mihriban Karaayvaz, Rebecca E. Silberman, Adam Langenbucher, Srinivas Vinod Saladi, Kenneth N. Ross, Elena Zarcaro, Andrea J Desmond, Murat Yıldırım, Varunika Vivekanandan, Hiranmayi Ravichandran et al. · 2020 · Science Advances
60. Analysis of Induced Pluripotent Stem Cells from a BRCA1 Mutant Family
    Abigail A. Soyombo, Yipin Wu, Lauren Kolski, Jonathan J. Rios, Dinesh Rakheja, Alice P. Chen, James Kehler, Heather Hampel, Alanna J. Coughran, Theodora Suzanne Ross · 2013 · Stem Cell Reports
61. Molecular marks for epigenetic identification of developmental and cancer stem cells
    Samir Kumar Patra, Moonmoon Deb, Aditi Patra · 2010 · Clinical Epigenetics
62. An “elite hacker”: breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity
    Boudreau, Aaron, van't Veer, Laura J., Bissell, Mina J. · 2012 · Cell Adhesion & Migration
63. Advances in the roles of glycyrrhizic acid in cancer therapy
    Yuqian Zhang, Zixuan Sheng, Jing Xiao, Yang Li, Jie Huang, Jing Jia, Xiansi Zeng, Li Li · 2023 · Frontiers in Pharmacology
64. Single-Cell Transcriptomic Analysis of Dental Pulp and Periodontal Ligament Stem Cells
    Yuchen Yang, Tomaz Alves, Michael Zhe Miao, Y.C. Wu, Gang Li, J. Lou, Hatice Hastürk, Thomas E. Van Dyke, Alpdoğan Kantarcı, Di Wu · 2023 · Journal of Dental Research
65. TOX3 is expressed in mammary ER+ epithelial cells and regulates ER target genes in luminal breast cancer
    Akop Seksenyan, Asha Kadavallore, Ann E. Walts, Brian de la Torre, Dror Berel, Samuel P. Strom, Parinaz Aliahmad, Vincent Anthony Funari, Jonathan G. Kaye · 2015 · BMC Cancer
66. Out-RANKing BRCA1 in Mutation Carriers
    Emma Nolan, Geoffrey John Lindeman, Jane E. Visvader · 2017 · Cancer Research
67. Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity
    Tamara Chamberlin, Joseph V. D’Amato, Lisa M. Arendt · 2017 · Breast Cancer Research
68. Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes
    Wen Bu, Zhenyu Liu, Weiyu Jiang, Chandandeep S. Nagi, Shixia Huang, Dean P. Edwards, Eunji Jo, Qianxing Mo, Chad J. Creighton, Susan Galloway Hilsenbeck et al. · 2018 · Cancer Research
69. Elevated Circulating IGF-I Promotes Mammary Gland Development and Proliferation
    Dara Cannata, Danielle E. Lann, Yingjie Wu, Sébastien Elis, Hui Sun, Shoshana Yakar, Deborah A. Lazzarino, Teresa L. Wood, Derek LeRoith · 2010 · Endocrinology
70. Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer
    Aaron R. Thorner, Joel S. Parker, Katherine A. Hoadley, Charles M. Perou · 2010 · PLoS ONE
71. Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells
    Christian H.K. Lehmann, GABRIELE JOBS, Markus Thomas, Helmut J. BURTSCHER, Manfred Kubbies · 2012 · International Journal of Oncology
72. Pubertal Bisphenol A Exposure Alters Murine Mammary Stem Cell Function Leading to Early Neoplasia in Regenerated Glands
    Danhan Wang, Hui Gao, Abhik M. Bandyopadhyay, Anqi Wu, I‐Tien Yeh, Yidong Chen, Yi Zou, Changjiang Huang, Christi A. Walter, Qiaoxiang Dong et al. · 2014 · Cancer Prevention Research
73. Live Multicellular Tumor Spheroid Models For High-Content Imaging and Screening In Cancer Drug Discovery
    Brian G. Reid, Taleen Jerjian, Purvi R. Patel, Qiong Zhou, Byong Hoon Yoo, Peter Kabos, Carol A. Sartorius, Daniel V. LaBarbera · 2014 · Current Chemical Genomics
74. Proof of region-specific multipotent progenitors in human breast epithelia
    Agla J. Fridriksdottir, René Villadsen, Mikkel Morsing, Marie Christine Klitgaard, Jiyoung Kim, OLE WILLIAM PETERSEN, Lone Rønnov‐Jessen · 2017 · Proceedings of the National Academy of Sciences
75. Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization
    Arindam Banerjee, Charles N. Birts, Matthew Darley, Rachel Parker, Alex H. Mirnezami, Jonathan J. West, Ramsey Cutress, Stephen A. Beers, Matthew J.J. Rose-Zerilli, Jeremy P. Blaydes · 2018 · Carcinogenesis
76. Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way
    Wei Li, Hao Wu, Shiyao Sui, Qin Wang, Shouping Xu, Da Pang · 2021 · Frontiers in Cell and Developmental Biology
77. Breast Cancer Heterogeneity in Primary and Metastatic Disease
    Lauren Kalinowski, Jodi M. Saunus, Amy E. McCart Reed, Sunil R. Lakhani · 2019 · Advances in experimental medicine and biology
78. Emerging role of interactions between tumor angiogenesis and cancer stem cells
    Shuai Lv, Yufei Liu, Changheng Xie, Chenyang Xue, Shi Du, Jing Yao · 2023 · Journal of Controlled Release
79. Active allies: hormones, stem cells and the niche in adult mammopoiesis
    Purna A. Joshi, Marco A. Di Grappa, Rama Khokha · 2012 · Trends in Endocrinology and Metabolism
80. Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours
    Luwei Tao, Dongxi Xiang, Ying Xie, Roderick Terry Bronson, Zhe Li · 2017 · Nature Communications
81. SOX11 promotes invasive growth and ductal carcinoma in situ progression
    Erik Oliemuller, Naoko Kogata, Philip J. Bland, Divya Kriplani, Frances M Daley, Syed Aleem Haider, Vandna Shah, Elinor J. Sawyer, Beatrice A. Howard · 2017 · The Journal of Pathology
82. Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
    Mark van Barele, Bernadette A. M. Heemskerk‐Gerritsen, Yvonne V. Louwers, Mijntje B. Vastbinder, John W.M. Martens, Maartje J. Hooning, Agnes Jager · 2021 · Cancers
83. Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
    Michael D. Iglesia, Reyka G. Jayasinghe, Siqi Chen, Nadezhda V. Terekhanova, John M. Herndon, Erik P. Storrs, Alla Y. Karpova, Daniel Cui Zhou, Nataly Naser Al Deen, Andrew T. Shinkle et al. · 2024 · Nature Cancer
84. Lmo2 expression defines tumor cell identity during T‐cell leukemogenesis
    Idoia García‐Ramírez, Sanil Bhatia, Guillermo Rodríguez-Hernández, Inés González‐Herrero, Carolin Walter, Sara González de Tena‐Dávila, Salma Parvin, Oskar A. Haas, Wilhelm Woessmann, Martin Stanulla et al. · 2018 · The EMBO Journal
85. Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features
    Vilde Drageset Haakensen, Ole Christian Lingjærde, Torben Lüders, Margit L. H. Riis, Aleix Prat, Melissa A. Troester, Marit Muri Holmen, Jan Ole Frantzen, Linda Romundstad, Dina Navjord et al. · 2011 · BMC Medical Genomics
86. YB-1 Transforms Human Mammary Epithelial Cells Through Chromatin Remodeling Leading to the Development of Basal-Like Breast Cancer
    Alastair Davies, Kristen M. Reipas, Mary Rose Pambid, Rachel Berns, Anna L. Stratford, Abbas Fotovati, Natalie S. Firmino, Arezoo Astanehe, Kaiji Hu, Christopher A. Maxwell et al. · 2014 · Stem Cells
87. Distinct Effects of EGFR Ligands on Human Mammary Epithelial Cell Differentiation
    Chandrani Mukhopadhyay, Xiangshan Zhao, Dulce M. Maroni, Vimla Band, Mayumi Naramura · 2013 · PLoS ONE
88. Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model
    Olivier Trédan, Magali Lacroix‐Triki, Séverine Guiu, Marie‐Ange Mouret‐Reynier, Jérôme Barrière, François‐Clément Bidard, Antoine-Laurent Braccini, Olivier Mir, Christian Villanueva, Philippe Barthélémy · 2014 · Targeted Oncology
89. Mammospheres from murine mammary stem cell-enriched basal cells: Clonal characteristics and repopulating potential
    Qiaoxiang Dong, Danhan Wang, Abhik M. Bandyopadhyay, Hui Gao, Karla M. Gorena, Kim Hildreth, Vivienne I. Rebel, Christi A. Walter, Changjiang Huang, Lu‐Zhe Sun · 2013 · Stem Cell Research
90. Epidemiology of Health Disparities in Relation to the Biology of Estrogen Receptor–Negative Breast Cancer
    Tanya Agurs‐Collins, Barbara Karen Dunn, Doris Browne, Karen A. Johnson, Ronald A. Lubet · 2010 · Seminars in Oncology
91. Dynamic rewiring of the human interactome by interferon signaling
    Craig H. Kerr, Michael A. Skinnider, Angel M. Madero, Daniel D.T. Andrews, R. Greg Stacey, Queenie W.T. Chan, Nikolay Stoynov, Eric Jan, Leonard J. Foster · 2020 · Genome biology
92. Evolving insights: how DNA repair pathways impact cancer evolution
    Jiadong Zhou, Xiao Albert Zhou, Ning Zhang, Jiadong Wang · 2020 · Cancer Biology and Medicine
93. Mapping Intellectual Structures and Research Hotspots of Triple Negative Breast Cancer: A Bibliometric Analysis
    Kai-jun Hao, Xiao Ping Jia, Wen-ting Dai, Ze-min Huo, Huaqiang Zhang, Jingwei Liu, Xiaobing Wang · 2022 · Frontiers in Oncology
94. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells
    Felicia Leccia, Luigi Del Vecchio, Elisabetta Mariotti, Rosa Di Noto, Anne‐Pierre Morel, Alain Puisieux, Francesco Salvatore, Stéphane Ansieau · 2014 · Molecular Cancer
95. The ΔNp63 Proteins Are Key Allies of BRCA1 in the Prevention of Basal-Like Breast Cancer
    Niamh E. Buckley, Susan J. Conlon, Karin Jirström, Elaine Williamson Kay, Nyree Crawford, Anthony O’Grady, Katherine M. Sheehan, Simon S. McDade, Ching‐Wei Wang, Dennis J. McCance et al. · 2011 · Cancer Research
96. Expression of the Pluripotency Transcription Factor OCT4 in the Normal and Aberrant Mammary Gland
    Foteini Hassiotou, Anna Rachel Hepworth, Adriana S. Beltrán, Michelle M. Mathews, Alison M. Stuebe, Peter Edwin Hartmann, Luis Filgueira, Pilar Blancafort · 2013 · Frontiers in Oncology
97. Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors
    Bo-Hyun Choi, Vipin Rawat, Jenny M. Hogstrom, Philippa A. Burns, Kelly O. Conger, Mete Emir Özgürses, Jaymin M. Patel, Tejas S. Mehta, Angelica Warren, Laura M. Selfors et al. · 2022 · Cell Reports
98. Elf5, hormones and cell fate
    Heather J Lee, Christopher John Ormandy · 2012 · Trends in Endocrinology and Metabolism
99. EZH2 promotes a bi-lineage identity in basal-like breast cancer cells
    Roy Zvi Granit, Yael Gabai, Tal Hadar, Yael Karamansha, L Liberman, Ithai Waldhorn, Irit Gat‐Viks, Aviv Regev, Bella Maly, Merav Darash‐Yahana et al. · 2012 · Oncogene
100. Cancer Cell of Origin: Spotlight on Luminal Progenitors
     Christine Louise Chaffer, Robert A. Weinberg · 2010 · Cell stem cell